![]()
|
|||
| |
|||
ANATOMIC
PATHOLOGY Immunophenotypic analysis of inflammatory breast cancers:
identification of an inflammatory signature Charafe-Jauffret E, Tarpin C, Bardou
VJ, Bertucci F, Ginestier
C, Braud AC, Puig B, Geneix J, Hassoun J, Birnbaum D, Jacquemier J, Viens P. Inflammatory
breast cancer (IBC) is a rare but very aggressive form of breast cancer. Its
definition is based on clinical criteria, but a molecular definition could be
useful when data are incomplete or features are missing. Recently, the identification
of overexpression of E-cadherin
in IBC has improved understanding of the molecular basis of this disease.
Consequently, the aim of this study was to try to determine an immunophenotypic 'signature' of IBC. A series of 80 cases
of IBC were compared with 552 non-IBC control cases and a model was elaborated
to evaluate the probability of an inflammatory carcinoma being present in any
clinical situation. Tissue microarrays (TMAs) were used to determine the immunohistochemical
profile of eight proteins including E-cadherin, EGFR, oestrogen and progesterone receptor
(ER and PR), MIB1, ERBB2, MUC1, and P53. All the parameters tested were
differentially expressed between IBC and control cases in univariate
analysis (p < 0.001). The five variables that were significantly associated
with IBC in multivariate analysis were E - cadherin
>/= 300 [HR = 5.64 (2.92-10.87)], ER negative [HR = 3.00 (1.67-5.51)], MIB1
> 20 [HR = 3.54 (1.87-6.71)], MUC1 cytoplasmic
staining [HR = 2.72 (1.49-4.96)], and ERBB2 positive 2+ or 3+ [HR = 2.46
(1.26-4.78)]. The probability that a breast cancer with this full phenotype at
diagnosis was an IBC was 90.5%. If any one of the five parameters was missing,
this probability dropped to 75% and was less than 50% when one, two, or three parameters
were present. The 5-year overall survival (OS) and 5-year disease-free survival
(DFS) of patients with IBC were not significantly different from those of the
non-IBC control group that expressed four or five parameters (nIBC-1), but this
nIBC-1 control group had a significantly worse outcome than the non-IBC control
group (nIBC-2) with only 0-3 parameters (p=0.0049 for OS and p < 0.0001 for
DFS). In conclusion, an immunophenotypic signature
was suggested for IBC. This could help to determine the worst cases,
independent of clinical criteria. J Pathol. 202(3): 265-73 2004 Diagnosis and
reporting of limited adenocarcinoma of the prostate
on needle biopsy Epstein
JI. The diagnosis of
limited adenocarcinoma of the prostate is one of the
more difficult challenges in surgical pathology. This paper highlights the
methodological approach to diagnosing limited cancer, based on a constellation
of features more commonly present in adenocarcinoma
than benign glands. In assessing small foci of atypical glands on needle
biopsy, one looks for differences between the benign glands and the atypical
glands in terms of nuclear features, cytoplasmic
features, and intraluminal contents. Only a few
features, such as glomerulations, mucinous
fibroplasia (collagenous micronodules), and perineural
invasion are diagnostic in and of themselves for prostate cancer. Immunohistochemistry may be a useful adjunct in the
diagnosis of limited adenocarcinoma of the prostate,
although as with any immunohistochemical studies,
there are problems with both sensitivity and specificity. Basal cell markers,
such as high molecular weight cytokeratin and more
recently, p63, highlight basal cells found in benign glands, yet are absent in adenocarcinoma of the prostate. However, not all benign
glands label uniformly with basal cell markers. Certain mimickers of adenocarcinoma of the prostate are even less frequently
labeled uniformly with these stains. Consequently, negative staining in a small
focus of atypical glands for basal cell markers is not diagnostic of adenocarcinoma of the prostate. More recently, a marker has
been identified that relatively selectively labels adenocarcinoma
of the prostate. AMACR will label the cytoplasm of approximately 80% of limited
adenocarcinoma of the prostate cases on needle
biopsy. In positive cases, not all of the glands will be positive and those
that are positive are often not intensely positive. Certain variants of adenocarcinoma of the prostate that are
a little more difficult to recognize, such as foamy glands adenocarcinoma,
pseudohyperplastic adenocarcinoma,
and atrophic adenocarcinoma, are labeled with AMACR
in only approximately 60-70% of cases. In addition to problems with
sensitivity, AMACR is not entirely specific for adenocarcinoma,
and will label almost all cases of high-grade prostatic
intraepithelial neoplasia, some foci of adenosis, and even some entirely benign glands. Finally,
this paper describes the significance of atypical or suspicious prostate needle
biopsies, and how to report the key diagnostic and prognostic information on
needle biopsy. Modern Pathology 17, 307-315, 2004
Proximal small-bowel mucosal villous intraepithelial
lymphocytes
N S
Goldstein Small-bowel biopsies are routinely obtained from adult patients as a screening tool to evaluate the possibility of gluten sensitivity (GS). Previous morphological criteria of GS including completely flattened villi are usually absent. In the context of screening for GS, an altered distribution density pattern of villous intraepithelial lymphocytes (IELs) is probably the most sensitive morphological feature to suggest the possibility of GS and prompt the initiation of further medical evaluation. Altered villous IEL density distribution is a more sensitive screening feature than villous IEL counts. With increased small-bowel GS screening biopsies, occasional adults without GS with complete villous flattening and numerous villous IELs are encountered. These patients are usually incorrectly diagnosed with GS. However, they do not respond to a gluten-free diet and slowly improve over months. Histopathology 44: 199-205, 2004
Experience With an Automated Microwave-Assisted Rapid
Tissue Processing Method Validation of Histologic
Quality and Impact on the Timeliness of Diagnostic Surgical Pathology Azorides
R. Morales, MD, Mehdi Nassiri,
MD, Rima Kanhoush, MD,
Vladimir Vincek, MD, PhD, and Mehrdad
Nadji, MD Authors studied
the effect of a fully automated microwave-assisted rapid tissue processor (RTP)
on histologic examination and on the turnaround time
for surgical pathology reports. A quality assurance program reviewed the histologic sections obtained by the rapid processing method
for the last 3 calendar years. In addition, the histologic
results from this method were compared blindly with those obtained from the
conventional overnight tissue processing (CTP) method by 9 pathologists with
different levels of experience. The surgical pathology turnaround times for 1
year of use of the RTP were compared with the last year for CTP. We found that
the RTP reproducibly yielded histologic material
comparable in quality to CTP. The turnaround time for surgical pathology
reports was improved substantially, and, in particular, same-day reporting was
achieved in approximately 55% of cases compared with less than 1% before use of
the RTP. Moreover, use of the RTP enhanced safety by eliminating formalin and xylene from the procedure. Am J Clin Pathol121: 528-536, 2004 A review of the emergence of Plasmodium falciparum-dominated malaria in irrigated areas of the Tyagi BK. Recently, there has been a resurgence of malaria in
several parts of Acta Trop 89(2): 227-39,2004 MICROBIOLOGY Comparison of six
biological markers for the diagnosis of tuberculous pleuritis Hiraki A, Aoe K, Eda R, Maeda T, Murakami
T, Sugi K, Takeyama H. Authors sought a marker to differentiate tuberculous pleural effusions from nontuberculous pleural effusions, which otherwise can be difficult. PATIENTS: Authors studied 55 patients with pleural effusions, 20 (36%) with tuberculous pleuritis and 35 (64%) with a nontuberculous etiology. Measurement and results: Pleural fluid levels of adenosine deaminase, interferon (INF)-gamma, interleukin (IL)-12p40, IL-18, immunosuppressive acidic protein, and soluble IL-2 receptors were measured and were subjected to receiver operating characteristic analysis. INF-gamma had the greatest sensitivity and specificity for tuberculous pleuritis among the six biological markers studied. CONCLUSION: The determination of INF-gamma levels in pleural fluid is the most informative in the diagnosis of tuberculous effusion. Chest 125(3): 987-9, 2004
Clinical and
laboratory observations of tuberculosis at a Mumbai ( D Gothi, J M Joshi Objectives: To study the positivity of sputum acid fast bacilli (AFB) smears in patients with pulmonary tuberculosis using 24 hour sputum collection. To detect HIV seropositivity in patients suffering from tuberculosis, and to analyse the pattern of tuberculosis disease in this subgroup. To determine the outcome of patients treated with directly observed therapy. Setting: The tuberculosis referral unit of a tertiary care hospital. Design: A total of 893
consecutive patients with tuberculosis, diagnosed between Results: Out of 893 patients with tuberculosis, 695 had pulmonary tuberculosis and 198 had extrapulmonary tuberculosis. Out of the 695 pulmonary tuberculosis patients, 673 (96.8%) were sputum smear AFB positive. Overall, 71 patients (8.0%) were HIV positive. The pattern of tuberculosis was the same in HIV seropositive and seronegative patients. Treatment outcome could be analysed in 112 out of 150 patients: 78 patients (70%) were declared cured or completed treatment. Conclusions: Sputum smear AFB could be a very sensitive test when a large quantity of sputum is used. The presence of HIV coinfection does not alter the clinical presentation. Only 70% of patients treated were cured/completed treatment, in spite of a strict directly observed therapy. Postgrad Med J 80:97100, 2004
The diagnosis of tuberculosis: what's old, what's new
Schluger NW. The
approach to the diagnosis of both active tuberculosis and latent infection has
changed very little in the past several decades. For active disease, sputum
smears with or without chest radiographs to aid in diagnostic accuracy, form
the cornerstone of the diagnostic approach in many high-burden countries. These
tests usually are supplemented by cultures when resources permit. The diagnosis
of latent infection still relies on the use of the tuberculin skin test using
purified protein derivative. The current global tuberculosis epidemic, which
features large numbers of patients with human immunodeficiency virus infection
and increasing rates of multidrug-resistant
tuberculosis, makes accurate and rapid diagnosis of tuberculosis more urgent
than ever before. Currently available technologies, most involving techniques
of DNA amplification, can substantially improve the accuracy of the diagnosis
of tuberculosis, although the use of such assays has been sharply limited
because of concerns about cost. However, economic analyses suggest that these
assays can be cost effective if they lead to sharp reductions in transmission
through earlier treatment of infectious cases. Semin Respir Infect. 18(4): 241-8, Dec. 2003
Bird flu (avian influenza) Bird flu is an
infection of birds caused by type A strains of the
influenza virus. According to the Centers for Disease Control and Prevention
(CDC), type A influenza virus can infect several
species of animals, including birds, pigs and horses. Influenza viruses that
infect birds are called avian influenza viruses. Health experts
once thought that avian flu could only infect birds and animals. But several
cases of human infections have been reported since 1997, including in According to the
CDC, avian influenza virus usually doesn't affect wild birds. But it can make
domesticated birds, such as chickens and turkeys, very sick and often kills
them. Avian flu is transmitted to humans by direct contact with the droppings
of an infected bird. In humans, avian flu is typically severe and fatal. Signs and symptoms
may include:
At this time,
there's no evidence that avian flu can spread from one person to another.
However, there's concern that if someone acquires avian influenza at the same
time as human influenza, the avian virus may mutate and develop the ability to
spread from person to person, leading to a human epidemic. Treatment of bird
flu in humans may include antiviral medications. Current influenza vaccines
don't protect against avian influenza strains. But such vaccines may be
developed. By Mayo Clinic staff,
BOTTOM LINE
Popular
Pathology Requisitions: The Hidden Meaning T Rajalakshmi Department of
Pathology,
J Clin Pathol 57:368 April 2004
|
|||
| Back Home | |||